Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1986 1
1987 17
1988 12
1989 36
1990 22
1991 56
1992 75
1993 107
1994 117
1995 148
1996 226
1997 263
1998 298
1999 275
2000 295
2001 324
2002 316
2003 272
2004 256
2005 277
2006 217
2007 229
2008 224
2009 206
2010 217
2011 229
2012 225
2013 258
2014 254
2015 268
2016 260
2017 248
2018 232
2019 116
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

6,200 results
Results by year
Filters applied: . Clear all
Page 1
Helicobacter pylori Infection
Crowe SE. N Engl J Med 2019 - Review. PMID 30893536
Antibiotic resistance in Helicobacter pylori
Alba C, et al. Curr Opin Infect Dis 2017 - Review. PMID 28704226
RECENT FINDINGS: Clarithromycin-resistant H. pylori has been recognized by the WHO as 'high priority', for which new antibiotics are needed. ...Eradication rates are dependent on the susceptibility of the strain to metronidazole and clarithromycin, being lower in patients infected with a resistant strain....
RECENT FINDINGS: Clarithromycin-resistant H. pylori has been recognized by the WHO as 'high priority', for which new antibiotics are …
Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia.
Namkoong H, et al. PLoS Pathog 2018. PMID 29621339 Free PMC article.
In this study, we investigated the functional significance of the expansion of myeloid-derived suppressor cell (MDSC)-like CD11b+Gr-1+ cells in response to the macrolide antibiotic clarithromycin (CAM) in mouse models of shock and post-influenza pneumococcal pneumonia as well as in humans. ...
In this study, we investigated the functional significance of the expansion of myeloid-derived suppressor cell (MDSC)-like CD11b+Gr-1+ cells …
Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics
Fallone CA, et al. Gastroenterology 2019 - Review. PMID 30998990
The guidelines recommend bismuth quadruple therapy for first-line treatment, replacing clarithromycin-based triple therapy. There is consensus for concomitant 4-drug therapy as an alternative, especially when bismuth is not available. When therapy is unsuccessful, it is likely due to resistance to clarithromycin, levofloxacin, and/or metronidazole; these drugs, if used previously, should be avoided in subsequent eradication attempts. ...
The guidelines recommend bismuth quadruple therapy for first-line treatment, replacing clarithromycin-based triple therapy. There is …
Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance
Hu Y, et al. Front Cell Infect Microbiol 2017 - Review. PMID 28529929 Free PMC article.
Helicobacter pylori monoresistance to clarithromycin, metronidazole or levofloxacin was common in most countries. However, the prevalence of amoxicillin and tetracycline resistance has remained low. Because H. pylori infection and reinfection present serious challenges and because H. pylori resistance to clarithromycin, metronidazole or levofloxacin remains high in most countries, the selection of an efficient regimen to eradicate H. pylori is critical. ...
Helicobacter pylori monoresistance to clarithromycin, metronidazole or levofloxacin was common in most countries. However, the preval …
Macrolide antibiotics for bronchiectasis
Kelly C, et al. Cochrane Database Syst Rev 2018 - Review. PMID 29543980 Free PMC article.
Four studies with 190 children used either azithromycin, clarithromycin, erythromycin, or roxithromycin.We included nine adult studies in our comparison between macrolides and placebo and two in our comparison with no intervention. ...
Four studies with 190 children used either azithromycin, clarithromycin, erythromycin, or roxithromycin.We included nine adult studie …
Effectiveness of clarithromycin in patients with yellow nail syndrome.
Matsubayashi S, et al. BMC Pulm Med 2018 - Clinical Trial. PMID 30111321 Free PMC article.
Since YNS is accompanied by chronic bronchial infection in more than half of patients, we hypothesized that treatment with clarithromycin (CAM) could be effective. ...
Since YNS is accompanied by chronic bronchial infection in more than half of patients, we hypothesized that treatment with clarithromycin
6,200 results
Jump to page
Feedback